Investor Relations
Board of committees
Bright Green Corporation
NASDAQ CM: BGXX
Investor Relations
Bright Green is leveraging automation and technologically driven research & development to cultivate pharmaceutical grade plants, including medical cannabis and marihuana, delivering consistent quality in a state-of-the-art, environmentally controlled, organic ecosystem.
| Audit Committee | Compensation Committee | Nominating And Corporate Governance Committee | Scientific Advisory Board | |
|---|---|---|---|---|
|
Robert Arnone |
|
|
|
|
|
Sean Deson |
|
|
|
|
|
Dean M. Valore |
|
|
|
|
| Audit Committee | Compensation Committee | Nominating And Corporate Governance Committee | Scientific Advisory Board | |
|---|---|---|---|---|
|
Robert Arnone |
|
|
|
|
|
Tamas Biro |
|
|
|
|
|
Dr. Alfie Morgan |
|
|
|
|
|
Terry Rafih |
|
|
|
|
|
Dominic Schiller |
|
|
|
|
|
Colin Stott |
|
|
|
|
|
Brian Thomas |
|
|
|
|
|
Dean M. Valore |
|
|
|
|
|
Guy Webber |
|
|
|
|
Copyright © 2023. All rights reserved.
